TY - JOUR AU - Foulkes, W. D. AU - Smith, I. E. AU - Reis-Filho, J. S. PY - 2010 DA - 2010// TI - Triple-negative breast Cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMra1001389 DO - 10.1056/NEJMra1001389 ID - Foulkes2010 ER - TY - JOUR AU - Isakoff, S. J. PY - 2010 DA - 2010// TI - Triple-negative breast cancer: role of specific chemotherapy agents JO - Cancer J VL - 16 UR - https://doi.org/10.1097/PPO.0b013e3181d24ff7 DO - 10.1097/PPO.0b013e3181d24ff7 ID - Isakoff2010 ER - TY - JOUR AU - Yu, X. AU - Zhang, Z. AU - Wang, Z. AU - Wu, P. AU - Qiu, F. AU - Huang, J. PY - 2016 DA - 2016// TI - Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis JO - Clin Transl Oncol VL - 18 UR - https://doi.org/10.1007/s12094-015-1391-y DO - 10.1007/s12094-015-1391-y ID - Yu2016 ER - TY - JOUR AU - Perdiguero, E. G. AU - Geissmann, F. PY - 2014 DA - 2014// TI - Identifying the infiltrators JO - Science. VL - 344 UR - https://doi.org/10.1126/science.1255117 DO - 10.1126/science.1255117 ID - Perdiguero2014 ER - TY - JOUR AU - Korkaya, H. AU - Liu, S. AU - Wicha, M. S. PY - 2011 DA - 2011// TI - Breast cancer stem cells, cytokine networks, and the tumor microenvironment JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI57099 DO - 10.1172/JCI57099 ID - Korkaya2011 ER - TY - JOUR AU - Ibrahim, E. M. AU - Al-Foheidi, M. E. AU - Al-Mansour, M. M. AU - Kazkaz, G. A. PY - 2014 DA - 2014// TI - The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis JO - Breast Cancer Res Treat VL - 148 UR - https://doi.org/10.1007/s10549-014-3185-2 DO - 10.1007/s10549-014-3185-2 ID - Ibrahim2014 ER - TY - JOUR AU - Seo, A. AU - Lee, H. AU - Kim, E. AU - Kim, H. AU - Jang, M. AU - Lee, H. PY - 2013 DA - 2013// TI - Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.634 DO - 10.1038/bjc.2013.634 ID - Seo2013 ER - TY - JOUR AU - Liu, S. AU - Lachapelle, J. AU - Leung, S. AU - Gao, D. AU - Foulkes, W. D. PY - 2012 DA - 2012// TI - CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer JO - Breast Cancer Res VL - 14 UR - https://doi.org/10.1186/bcr3148 DO - 10.1186/bcr3148 ID - Liu2012 ER - TY - JOUR AU - Stanton, S. E. AU - Disis, M. L. PY - 2016 DA - 2016// TI - Clinical significance of tumor-infiltrating lymphocytes in breast cancer JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0165-6 DO - 10.1186/s40425-016-0165-6 ID - Stanton2016 ER - TY - JOUR AU - Takenaka, M. AU - Seki, N. AU - Toh, U. AU - Hattori, S. AU - Kawahara, A. AU - Yamaguchi, T. PY - 2013 DA - 2013// TI - FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis JO - Mol Clin Oncol VL - 1 UR - https://doi.org/10.3892/mco.2013.107 DO - 10.3892/mco.2013.107 ID - Takenaka2013 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gotzsche, P. C. AU - Ioannidis, J. P. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration JO - J Clin Epidemiol VL - 62 UR - https://doi.org/10.1016/j.jclinepi.2009.06.006 DO - 10.1016/j.jclinepi.2009.06.006 ID - Liberati2009 ER - TY - JOUR AU - Fisher, B. AU - Bryant, J. AU - Wolmark, N. AU - Mamounas, E. AU - Brown, A. AU - Fisher, E. R. PY - 1998 DA - 1998// TI - Effect of preoperative chemotherapy on the outcome of women with operable breast cancer JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.8.2672 DO - 10.1200/JCO.1998.16.8.2672 ID - Fisher1998 ER - TY - JOUR AU - Ovcaricek, T. AU - Frkovic, S. AU - Matos, E. AU - Mozina, B. AU - Borstnar, S. PY - 2011 DA - 2011// TI - Triple negative breast cancer-prognostic factors and survival JO - Radiol Oncol VL - 45 UR - https://doi.org/10.2478/v10019-010-0054-4 DO - 10.2478/v10019-010-0054-4 ID - Ovcaricek2011 ER - TY - JOUR AU - Sterne, J. A. AU - Hernan, M. A. AU - Reeves, B. C. AU - Savovic, J. AU - Berkman, N. D. AU - Viswanathan, M. PY - 2016 DA - 2016// TI - ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JO - Bmj. VL - 355 UR - https://doi.org/10.1136/bmj.i4919 DO - 10.1136/bmj.i4919 ID - Sterne2016 ER - TY - JOUR AU - Hayden, J. A. AU - Windt, D. A. AU - Cartwright, J. L. AU - Cote, P. AU - Bombardier, C. PY - 2013 DA - 2013// TI - Assessing bias in studies of prognostic factors JO - Ann Intern Med VL - 158 UR - https://doi.org/10.7326/0003-4819-158-4-201302190-00009 DO - 10.7326/0003-4819-158-4-201302190-00009 ID - Hayden2013 ER - TY - BOOK AU - Manager, R. PY - 2008 DA - 2008// TI - Version 5.0. The Nordic Cochrane Centre PB - The Cochrane Collaboration Copenhagen CY - Denmark ID - Manager2008 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Adams, S. AU - Gray, R. J. AU - Demaria, S. AU - Goldstein, L. AU - Perez, E. A. AU - Shulman, L. N. PY - 2014 DA - 2014// TI - Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.55.0491 DO - 10.1200/JCO.2013.55.0491 ID - Adams2014 ER - TY - JOUR AU - AiErken, N. AU - Shi, H. J. AU - Zhou, Y. AU - Shao, N. AU - Zhang, J. AU - Shi, Y. PY - 2017 DA - 2017// TI - High PD-L1 expression is closely associated with tumor-infiltrating lymphocytes and leads to good clinical outcomes in Chinese triple negative breast Cancer patients JO - Int J Biol Sci VL - 13 UR - https://doi.org/10.7150/ijbs.20868 DO - 10.7150/ijbs.20868 ID - AiErken2017 ER - TY - JOUR AU - Althobiti, M. AU - Aleskandarany, M. A. AU - Joseph, C. AU - Toss, M. AU - Mongan, N. AU - Diez-Rodriguez, M. PY - 2018 DA - 2018// TI - Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance JO - Histopathology. VL - 73 UR - https://doi.org/10.1111/his.13695 DO - 10.1111/his.13695 ID - Althobiti2018 ER - TY - JOUR AU - Asano, Y. AU - Kashiwagi, S. AU - Goto, W. AU - Takada, K. AU - Takahashi, K. AU - Hatano, T. PY - 2018 DA - 2018// TI - Prediction of treatment response to Neoadjuvant chemotherapy in breast Cancer by subtype using tumor-infiltrating lymphocytes JO - Anticancer Res VL - 38 UR - https://doi.org/10.21873/anticanres.12604 DO - 10.21873/anticanres.12604 ID - Asano2018 ER - TY - JOUR AU - Byun, K. D. AU - Hwang, H. J. AU - Park, K. J. AU - Kim, M. C. AU - Cho, S. H. AU - Ju, M. H. PY - 2018 DA - 2018// TI - T-cell immunoglobulin mucin 3 expression on tumor infiltrating lymphocytes as a positive prognosticator in triple-negative breast cancer JO - J Breast Cancer VL - 21 UR - https://doi.org/10.4048/jbc.2018.21.e61 DO - 10.4048/jbc.2018.21.e61 ID - Byun2018 ER - TY - JOUR AU - Cerbelli, B. AU - Pernazza, A. AU - Botticelli, A. AU - Fortunato, L. AU - Monti, M. AU - Sciattella, P. PY - 2017 DA - 2017// TI - PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy? JO - Biomed Res Int VL - 2017 UR - https://doi.org/10.1155/2017/1750925 DO - 10.1155/2017/1750925 ID - Cerbelli2017 ER - TY - JOUR AU - Denkert, C. AU - Minckwitz, G. AU - Brase, J. C. AU - Sinn, B. V. AU - Gade, S. AU - Kronenwett, R. PY - 2015 DA - 2015// TI - Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.1967 DO - 10.1200/JCO.2014.58.1967 ID - Denkert2015 ER - TY - JOUR AU - Denkert, C. AU - Minckwitz, G. AU - Darb-Esfahani, S. AU - Lederer, B. AU - Heppner, B. I. AU - Weber, K. E. PY - 2018 DA - 2018// TI - Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(17)30904-X DO - 10.1016/S1470-2045(17)30904-X ID - Denkert2018 ER - TY - JOUR AU - Dieci, M. V. AU - Criscitiello, C. AU - Goubar, A. AU - Viale, G. AU - Conte, P. AU - Guarneri, V. PY - 2014 DA - 2014// TI - Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt556 DO - 10.1093/annonc/mdt556 ID - Dieci2014 ER - TY - JOUR AU - Dieci, M. V. AU - Mathieu, M. C. AU - Guarneri, V. AU - Conte, P. AU - Delaloge, S. AU - Andre, F. PY - 2015 DA - 2015// TI - Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv239 DO - 10.1093/annonc/mdv239 ID - Dieci2015 ER - TY - JOUR AU - Galvez, M. AU - Castaneda, C. A. AU - Sanchez, J. AU - Castillo, M. AU - Rebaza, L. P. AU - Calderon, G. PY - 2018 DA - 2018// TI - Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy JO - World J Clin Oncol VL - 9 UR - https://doi.org/10.5306/wjco.v9.i2.33 DO - 10.5306/wjco.v9.i2.33 ID - Galvez2018 ER - TY - JOUR AU - Goto, W. AU - Kashiwagi, S. AU - Asano, Y. AU - Takada, K. AU - Takahashi, K. AU - Hatano, T. PY - 2018 DA - 2018// TI - Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy JO - ESMO Open VL - 3 UR - https://doi.org/10.1136/esmoopen-2017-000305 DO - 10.1136/esmoopen-2017-000305 ID - Goto2018 ER - TY - JOUR AU - Herrero-Vicent, C. AU - Guerrero, A. AU - Gavila, J. AU - Gozalbo, F. AU - Hernandez, A. AU - Sandiego, S. PY - 2017 DA - 2017// TI - Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy JO - Ecancermedicalscience VL - 11 UR - https://doi.org/10.3332/ecancer.2017.759 DO - 10.3332/ecancer.2017.759 ID - Herrero-Vicent2017 ER - TY - JOUR AU - Hida, A. I. AU - Sagara, Y. AU - Yotsumoto, D. AU - Kanemitsu, S. AU - Kawano, J. AU - Baba, S. PY - 2016 DA - 2016// TI - Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between triple-negative and HER2-positive breast cancers treated with standard systemic therapies JO - Breast Cancer Res Treat VL - 158 UR - https://doi.org/10.1007/s10549-016-3848-2 DO - 10.1007/s10549-016-3848-2 ID - Hida2016 ER - TY - JOUR AU - Jang, N. AU - Kwon, H. J. AU - Park, M. H. AU - Kang, S. H. AU - Bae, Y. K. PY - 2018 DA - 2018// TI - Prognostic value of tumor-infiltrating lymphocyte density assessed using a standardized method based on molecular subtypes and adjuvant chemotherapy in invasive breast Cancer JO - Ann Surg Oncol VL - 25 UR - https://doi.org/10.1245/s10434-017-6332-2 DO - 10.1245/s10434-017-6332-2 ID - Jang2018 ER - TY - JOUR AU - Kim, J. Y. AU - Heo, S. H. AU - Choi, S. K. AU - Song, I. H. AU - Park, I. A. AU - Kim, Y. A. PY - 2017 DA - 2017// TI - Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes JO - Virchows Arch VL - 470 UR - https://doi.org/10.1007/s00428-017-2083-5 DO - 10.1007/s00428-017-2083-5 ID - Kim2017 ER - TY - JOUR AU - Krishnamurti, U. AU - Wetherilt, C. S. AU - Yang, J. AU - Peng, L. AU - Li, X. PY - 2017 DA - 2017// TI - Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers JO - Hum Pathol VL - 64 UR - https://doi.org/10.1016/j.humpath.2017.01.004 DO - 10.1016/j.humpath.2017.01.004 ID - Krishnamurti2017 ER - TY - JOUR AU - Lee, H. J. AU - Park, I. A. AU - Song, I. H. AU - Shin, S. J. AU - Kim, J. Y. AU - Yu, J. H. PY - 2016 DA - 2016// TI - Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer JO - J Clin Pathol VL - 69 UR - https://doi.org/10.1136/jclinpath-2015-203089 DO - 10.1136/jclinpath-2015-203089 ID - Lee2016 ER - TY - JOUR AU - Leon-Ferre, R. A. AU - Polley, M. Y. AU - Liu, H. AU - Gilbert, J. A. AU - Cafourek, V. AU - Hillman, D. W. PY - 2018 DA - 2018// TI - Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer JO - Breast Cancer Res Treat VL - 167 UR - https://doi.org/10.1007/s10549-017-4499-7 DO - 10.1007/s10549-017-4499-7 ID - Leon-Ferre2018 ER - TY - JOUR AU - Li, X. X. AU - Wetherilt, C. S. AU - Krishnamurti, U. AU - Yang, J. AU - Ma, Y. M. AU - Styblo, T. M. PY - 2016 DA - 2016// TI - Stromal PD-L1 expression is associated with better disease-free survival in triple-negative breast Cancer JO - Am J Clin Pathol VL - 146 UR - https://doi.org/10.1093/ajcp/aqw134 DO - 10.1093/ajcp/aqw134 ID - Li2016 ER - TY - JOUR AU - Loi, S. AU - Michiels, S. AU - Salgado, R. AU - Sirtaine, N. AU - Jose, V. AU - Fumagalli, D. PY - 2014 DA - 2014// TI - Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu112 DO - 10.1093/annonc/mdu112 ID - Loi2014 ER - TY - JOUR AU - Luen, S. J. AU - Salgado, R. AU - Dieci, M. V. AU - Vingiani, A. AU - Curigliano, G. AU - Gould, R. E. PY - 2019 DA - 2019// TI - Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy JO - Ann Oncol VL - 30 UR - https://doi.org/10.1093/annonc/mdy547 DO - 10.1093/annonc/mdy547 ID - Luen2019 ER - TY - JOUR AU - Matsumoto, H. AU - Thike, A. A. AU - Li, H. H. AU - Yeong, J. AU - Koo, S. L. AU - Dent, R. A. PY - 2016 DA - 2016// TI - Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer JO - Breast Cancer Res Treat VL - 156 UR - https://doi.org/10.1007/s10549-016-3743-x DO - 10.1007/s10549-016-3743-x ID - Matsumoto2016 ER - TY - JOUR AU - McIntire, P. J. AU - Irshaid, L. AU - Liu, Y. F. AU - Chen, Z. M. AU - Menken, F. AU - Nowak, E. PY - 2018 DA - 2018// TI - Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer JO - Clin Breast Cancer VL - 18 UR - https://doi.org/10.1016/j.clbc.2018.04.019 DO - 10.1016/j.clbc.2018.04.019 ID - McIntire2018 ER - TY - JOUR AU - Miyashita, M. AU - Sasano, H. AU - Tamaki, K. AU - Chan, M. AU - Hirakawa, H. AU - Suzuki, A. PY - 2014 DA - 2014// TI - Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy JO - Breast Cancer Res Treat VL - 148 UR - https://doi.org/10.1007/s10549-014-3197-y DO - 10.1007/s10549-014-3197-y ID - Miyashita2014 ER - TY - JOUR AU - Mori, H. AU - Kubo, M. AU - Yamaguchi, R. AU - Nishimura, R. AU - Osako, T. AU - Arima, N. PY - 2017 DA - 2017// TI - The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer JO - Oncotarget. VL - 8 ID - Mori2017 ER - TY - JOUR AU - O'Loughlin, M. AU - Andreu, X. AU - Bianchi, S. AU - Chemielik, E. AU - Cordoba, A. AU - Cserni, G. PY - 2018 DA - 2018// TI - Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study JO - Breast Cancer Res Treat VL - 171 UR - https://doi.org/10.1007/s10549-018-4825-8 DO - 10.1007/s10549-018-4825-8 ID - O'Loughlin2018 ER - TY - JOUR AU - Ono, M. AU - Tsuda, H. AU - Shimizu, C. AU - Yamamoto, S. AU - Shibata, T. AU - Yamamoto, H. PY - 2012 DA - 2012// TI - Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1554-7 DO - 10.1007/s10549-011-1554-7 ID - Ono2012 ER - TY - JOUR AU - Park, H. S. AU - Heo, I. AU - Kim, J. Y. AU - Kim, S. AU - Nam, S. AU - Park, S. PY - 2016 DA - 2016// TI - No effect of tumor-infiltrating lymphocytes (TILs) on prognosis in patients with early triple-negative breast cancer: validation of recommendations by the international TILs working group 2014 JO - J Surg Oncol VL - 114 UR - https://doi.org/10.1002/jso.24275 DO - 10.1002/jso.24275 ID - Park2016 ER - TY - JOUR AU - Pruneri, G. AU - Gray, K. P. AU - Vingiani, A. AU - Viale, G. AU - Curigliano, G. AU - Criscitiello, C. PY - 2016 DA - 2016// TI - Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00 JO - Breast Cancer Res Treat VL - 158 UR - https://doi.org/10.1007/s10549-016-3863-3 DO - 10.1007/s10549-016-3863-3 ID - Pruneri2016 ER - TY - JOUR AU - Pruneri, G. AU - Vingiani, A. AU - Bagnardi, V. AU - Rotmensz, N. AU - Rose, A. AU - Palazzo, A. PY - 2016 DA - 2016// TI - Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv571 DO - 10.1093/annonc/mdv571 ID - Pruneri2016 ER - TY - JOUR AU - Ruan, M. AU - Tian, T. AU - Rao, J. AU - Xu, X. AU - Yu, B. AU - Yang, W. PY - 2018 DA - 2018// TI - Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers JO - Diagn Pathol VL - 13 UR - https://doi.org/10.1186/s13000-018-0743-7 DO - 10.1186/s13000-018-0743-7 ID - Ruan2018 ER - TY - JOUR AU - Tian, T. AU - Ruan, M. AU - Yang, W. AU - Shui, R. PY - 2016 DA - 2016// TI - Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers JO - Oncotarget. VL - 7 ID - Tian2016 ER - TY - JOUR AU - Urru, S. A. M. AU - Gallus, S. AU - Bosetti, C. AU - Moi, T. AU - Medda, R. AU - Sollai, E. PY - 2018 DA - 2018// TI - Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-017-3969-y DO - 10.1186/s12885-017-3969-y ID - Urru2018 ER - TY - JOUR AU - West, N. AU - Kost, S. AU - Martin, S. AU - Milne, K. AU - Deleeuw, R. AU - Nelson, B. PY - 2013 DA - 2013// TI - Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2012.524 DO - 10.1038/bjc.2012.524 ID - West2013 ER - TY - JOUR AU - Yeong, J. AU - Thike, A. A. AU - Lim, J. C. T. AU - Lee, B. AU - Li, H. H. AU - Wong, S. C. PY - 2017 DA - 2017// TI - Higher densities of Foxp3(+) regulatory T cells are associated with better prognosis in triple-negative breast cancer JO - Breast Cancer Res Treat VL - 163 UR - https://doi.org/10.1007/s10549-017-4161-4 DO - 10.1007/s10549-017-4161-4 ID - Yeong2017 ER - TY - JOUR AU - Demaria, S. AU - Volm, M. D. AU - Shapiro, R. L. AU - Yee, H. T. AU - Oratz, R. AU - Formenti, S. C. PY - 2001 DA - 2001// TI - Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy JO - Clin Cancer Res VL - 7 ID - Demaria2001 ER - TY - JOUR AU - Liu, S. AU - Duan, X. AU - Xu, L. AU - Xin, L. AU - Cheng, Y. AU - Liu, Q. PY - 2015 DA - 2015// TI - Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy JO - Breast Cancer Res Treat VL - 154 UR - https://doi.org/10.1007/s10549-015-3617-7 DO - 10.1007/s10549-015-3617-7 ID - Liu2015 ER - TY - JOUR AU - West, N. R. AU - Milne, K. AU - Truong, P. T. AU - Macpherson, N. AU - Nelson, B. H. AU - Watson, P. H. PY - 2011 DA - 2011// TI - Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3072 DO - 10.1186/bcr3072 ID - West2011 ER - TY - JOUR AU - Mao, Y. AU - Qu, Q. AU - Chen, X. AU - Huang, O. AU - Wu, J. AU - Shen, K. PY - 2016 DA - 2016// TI - The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0152500 DO - 10.1371/journal.pone.0152500 ID - Mao2016 ER - TY - JOUR AU - Mao, Y. a. n. AU - Qu, Q. i. n. g. AU - Zhang, Y. u. z. i. AU - Liu, J. u. n. j. u. n. AU - Shen, K. u. n. w. e. i. PY - 2014 DA - 2014// TI - Tumor infiltrating lymphocytes (TIL) to predict response to neoadjuvant chemotherapy in breast cancer: A systemic review and meta-analysis JO - Journal of Clinical Oncology VL - 32 UR - https://doi.org/10.1200/jco.2014.32.26_suppl.138 DO - 10.1200/jco.2014.32.26_suppl.138 ID - Mao2014 ER - TY - JOUR AU - Carbognin, L. AU - Pilotto, S. AU - Nortilli, R. AU - Brunelli, M. AU - Nottegar, A. AU - Sperduti, I. PY - 2016 DA - 2016// TI - Predictive and prognostic role of tumor-infiltrating lymphocytes for early breast Cancer according to disease subtypes: sensitivity analysis of randomized trials in adjuvant and Neoadjuvant setting JO - Oncologist VL - 21 UR - https://doi.org/10.1634/theoncologist.2015-0307 DO - 10.1634/theoncologist.2015-0307 ID - Carbognin2016 ER -